Page 3 - Lancet Report

Data shows booster Covid shots 'not appropriate' for public: Lancet

Vaccine efficacy against severe Covid-19 is so high, even for the Delta variant, that booster doses for the general population are "not appropriate" at this stage in the pandemic, a Lancet report said

Covid vaccine boosters not 'appropriate' at this stage: Lancet study

Vaccine efficacy against severe Covid-19, even for delta variant, is so high that booster doses for the general population are not appropriate at this stage in pandemic, according to a Lancet review

India needs to do more on hypertension, says Lancet global survey

Marginal increase in the number of people living with the ailment but diagnosis, treatment and control still need to catch up with best practices

Covid vaccine benefits far outweigh rare risk of facial paralysis: Lancet

The beneficial effects of COVID vaccines far outweigh the risk of facial paralysis on one side of the face known as Bell's Palsy, confirms a study published in The Lancet Infectious Diseases journal

India Covid Dispatch: Experts say it's time to send kids back to schools

Flu shot may protect against severe Covid effects, long-lasting Covid symptoms rare in children and other stories from around the country on the fight against the pandemic

Long-lasting coronavirus symptoms rare in children: Lancet study

Most children who develop COVID-19 symptoms recover after six days, and the number who experience symptoms beyond four weeks is low, according to a large UK study published in The Lancet Child & Adolescent Health journal. The study, based on data reported through a smartphone app by parents and carers, provides the first detailed description of COVID-19 illness in symptomatic school-aged children. "It is reassuring that the number of children experiencing long-lasting symptoms of COVID-19 symptoms is low. Nevertheless, a small number of children do experience long illness with COVID-19, and our study validates the experiences of these children and their families," said Professor Emma Duncan, lead author of the study, from King's College London, UK. The researchers noted that some adults experience a prolonged illness after COVID-19, described as long-COVID, where symptoms persist for four weeks or longer, but it is not known whether children can develop a similar condition or how .

Increased risk of heart attack in first two weeks following Covid: Lancet

The risk of heart attack and stroke is increased three-fold in the first two weeks following Covid-19, according to a study published in The Lancet journal.

119,000 Indian children lost caregivers due to Covid in 14 months: Report

More than 1.5 million children in 21 countries, including 119,000 from India, lost their primary and secondary caregivers to Covid-19 during the first 14 months of the pandemic, according to Lancet

Alcohol linked to over 62,000 cancer cases in India last year: Lancet study

Alcohol consumption was associated with 62,100 or five per cent of newly diagnosed cancer cases last year in India, according to a study published in The Lancet Oncology journal

Pfizer jab produces less antibodies against Delta variant: Lancet

People fully vaccinated with two doses of the Pfizer-BioNTech vaccine are likely to have more than five times lower levels of neutralising antibodies against the Delta variant

India could see 1 million Covid-19 deaths by August 1, says Lancet

The editorial in the medical journal has quoted Institute for Health Metrics and Evaluation data

Study sheds light on ten reasons why the coronavirus is airborne: Lancet

The evidence supporting airborne transmission is overwhelming, and evidence supporting large droplet transmission is almost non-existent, says a researcher

Bharat Biotech's Covaxin safe, immunises for at least 3 months: Lancet

Probability of side effects from vaccine 10-12%, 6x lower than other shots

Bharat Biotech's Covaxin has tolerable safety, says Lancet study

Sharing the interim findings, the paper said that the vaccine was well tolerated in all dose groups with no vaccine-related adverse events

Improving India's air may prevent 7% of pregnancy losses: Lancet

In a first, a Lancet study has indicated that meeting India's air quality targets across south Asia may prevent 7 per cent of pregnancy losses

Ban on public events can curb Covid transmission rate by 24%: Lancet study

Customers can book the model at their nearest Ducati dealerships, and the deliveries will begin in the first week of November, it added

India gained more than a decade of life expectancy since 1990: Lancet

The study, published in the Lancet journal, noted that life expectancy in India has risen from 59.6 years in 1990 to 70.8 years in 2019, ranging from 77.3 years in Kerala to 66.9 years in UP

Russia's Covid-19 vaccine shows potential in peer review, Lancet reports

Sputnik V induced an antibody response in all participants in early trials and found no serious adverse effects.

Oxford-Astra Covid-19 vaccine shows dual immune action, says researcher

Study shows the vaccine is safe, but it is still too soon to know if it can stop people from being infected

Covid-19 vaccine: Oxford candidate safe, shows immune response in trial

The preliminary results of the phase 1-2 trial, published in The Lancet journal, involved 1,107 healthy adults, and found that the vaccine induced an immune response both via antibodies and T-cells